Actelion buys U.S.-based firm with cancer drug in development
ZURICH (Reuters) - Actelion said it will acquire Ceptaris, a privately held U.S.-based specialty pharmaceutical company developing a topical drug, Val...
Source: http://health.yahoo.net/news/s/nm/actelion-buys-u-s-based-firm-with-cancer-drug-in-development
No comments:
Post a Comment